BioCentury
ARTICLE | Regulation

Emergency preparedness

Why FDA Commissioner Gottlieb thinks licensing antibiotics can stimulate R&D

June 23, 2018 12:15 AM UTC

Borrowing a page from the software industry, FDA Commissioner Scott Gottlieb believes that licensing rather than selling certain antibiotics could help address the crisis of multidrug resistant pathogens. He is hoping to work with CMS to test the idea in Medicare.

The licensing proposal aims to change what all parties agree is a broken commercial model for antibiotics by de-linking revenue from unit volume...